Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035161 | SCV000058802 | likely benign | not specified | 2011-04-22 | criteria provided, single submitter | clinical testing | 3082+8delG in intron 24 of FBN1: This variant has not been previously reported, but is not expected to be of clinical significance because it is not located in the conserved region of the splicing consensus sequence. |
Gene |
RCV000181401 | SCV000233703 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2014-08-18 | criteria provided, single submitter | clinical testing | The variant is found in TAAD panel(s). |
Eurofins Ntd Llc |
RCV000035161 | SCV000336718 | benign | not specified | 2015-11-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000467956 | SCV000557033 | benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-01-25 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000035161 | SCV000603635 | benign | not specified | 2018-08-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000181401 | SCV002608829 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-03-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000181401 | SCV003838357 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-04-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029722 | SCV000052375 | benign | Marfan syndrome | 2014-07-17 | no assertion criteria provided | clinical testing | |
Center for Medical Genetics Ghent, |
RCV000029722 | SCV000786920 | uncertain significance | Marfan syndrome | 2017-11-07 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001579674 | SCV001808109 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000035161 | SCV001965350 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004532412 | SCV004743739 | benign | FBN1-related disorder | 2019-05-17 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |